93 related articles for article (PubMed ID: 20533297)
1. Activin A and bone metastasis.
Leto G
J Cell Physiol; 2010 Nov; 225(2):302-9. PubMed ID: 20533297
[TBL] [Abstract][Full Text] [Related]
2. Activin is a potent growth suppressor of epithelial ovarian cancer cells.
Ramachandran A; Marshall ES; Love DR; Baguley BC; Shelling AN
Cancer Lett; 2009 Nov; 285(2):157-65. PubMed ID: 19493612
[TBL] [Abstract][Full Text] [Related]
3. Activins and cell migration.
Kang HY; Shyr CR
Vitam Horm; 2011; 85():129-48. PubMed ID: 21353879
[TBL] [Abstract][Full Text] [Related]
4. Modulation of activin and BMP signaling.
Harrison CA; Wiater E; Gray PC; Greenwald J; Choe S; Vale W
Mol Cell Endocrinol; 2004 Oct; 225(1-2):19-24. PubMed ID: 15451563
[TBL] [Abstract][Full Text] [Related]
5. Antagonists of activin signaling: mechanisms and potential biological applications.
Harrison CA; Gray PC; Vale WW; Robertson DM
Trends Endocrinol Metab; 2005 Mar; 16(2):73-8. PubMed ID: 15734148
[TBL] [Abstract][Full Text] [Related]
6. The activin axis in liver biology and disease.
Rodgarkia-Dara C; Vejda S; Erlach N; Losert A; Bursch W; Berger W; Schulte-Hermann R; Grusch M
Mutat Res; 2006; 613(2-3):123-37. PubMed ID: 16997617
[TBL] [Abstract][Full Text] [Related]
7. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
Kang HY; Huang HY; Hsieh CY; Li CF; Shyr CR; Tsai MY; Chang C; Chuang YC; Huang KE
J Bone Miner Res; 2009 Jul; 24(7):1180-93. PubMed ID: 19257827
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
Guise TA; Chirgwin JM
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
[TBL] [Abstract][Full Text] [Related]
9. Activins and inhibins and their signaling.
Vale W; Wiater E; Gray P; Harrison C; Bilezikjian L; Choe S
Ann N Y Acad Sci; 2004 Dec; 1038():142-7. PubMed ID: 15838109
[TBL] [Abstract][Full Text] [Related]
10. Role of activin, transforming growth factor-beta and bone morphogenetic protein 15 in regulating zebrafish oocyte maturation.
Tan Q; Balofsky A; Weisz K; Peng C
Comp Biochem Physiol A Mol Integr Physiol; 2009 May; 153(1):18-23. PubMed ID: 18838125
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation.
Gilchrist RB; Ritter LJ; Myllymaa S; Kaivo-Oja N; Dragovic RA; Hickey TE; Ritvos O; Mottershead DG
J Cell Sci; 2006 Sep; 119(Pt 18):3811-21. PubMed ID: 16926195
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta superfamily expression and actions in the endometrium and placenta.
Jones RL; Stoikos C; Findlay JK; Salamonsen LA
Reproduction; 2006 Aug; 132(2):217-32. PubMed ID: 16885531
[TBL] [Abstract][Full Text] [Related]
13. The role of activins and follistatins in skin and hair follicle development and function.
McDowall M; Edwards NM; Jahoda CA; Hynd PI
Cytokine Growth Factor Rev; 2008; 19(5-6):415-26. PubMed ID: 18922734
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of bone morphogenetic protein, transforming growth factor beta, and activin early response genes during osteoblastic cell differentiation.
de Jong DS; van Zoelen EJ; Bauerschmidt S; Olijve W; Steegenga WT
J Bone Miner Res; 2002 Dec; 17(12):2119-29. PubMed ID: 12469906
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.
Goumans MJ; Mummery C
Int J Dev Biol; 2000 Apr; 44(3):253-65. PubMed ID: 10853822
[TBL] [Abstract][Full Text] [Related]
16. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
Keah HH; Hearn MT
J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
[TBL] [Abstract][Full Text] [Related]
17. Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring?
Andreev K; Zenkel M; Kruse F; Jünemann A; Schlötzer-Schrehardt U
Exp Eye Res; 2006 Nov; 83(5):1162-70. PubMed ID: 16879818
[TBL] [Abstract][Full Text] [Related]
18. [Transforming growth factor-beta superfamily in the regulation of new bone formation].
Li X; Huang X; Qi ZL; Wang W
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Mar; 16(2):126-9. PubMed ID: 11944520
[TBL] [Abstract][Full Text] [Related]
19. Activins and activin antagonists in the human ovary and ovarian cancer.
Reader KL; Gold E
Mol Cell Endocrinol; 2015 Nov; 415():126-32. PubMed ID: 26277402
[TBL] [Abstract][Full Text] [Related]
20. Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis.
Beuschlein F; Looyenga BD; Reincke M; Hammer GD
Horm Metab Res; 2004 Jun; 36(6):392-6. PubMed ID: 15241730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
